Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

0
Player Avatar marsuculix (< 20) Submitted: 2/7/2013 4:35:28 AM : Outperform Start Price: $39.86 GILD Score: +10.74

solid company - excellent fundamentials with lots of cash and a nice FCF...

Featured Broker Partners


Advertisement